Editorial draft — not for publication yet. Methylphenidate content needs review by a qualified UK healthcare professional before publication. For advice about your own prescription, contact your prescriber or pharmacist.

Quick answer

NICE recommends methylphenidate as first-line pharmacological treatment for children aged 5 and over and young people with ADHD. For adults, NICE recommends methylphenidate or lisdexamfetamine as first-line medicine options when ADHD symptoms continue to cause significant impairment after environmental modifications have been reviewed.

Brand-specific product guides for Methylphenidate: Ritalin, Alaradate, Methyphen. These are separate from the generic guide.

Methylphenidate is one option within ADHD care

This does not mean methylphenidate is suitable for everyone or should be started without an ADHD assessment. NICE says diagnosis and medication management should be provided by professionals trained in ADHD.

Medication choice is individual

The prescriber considers age, symptoms, daily routine, medical history, other medicines, product licensing, release duration, side effects and patient preference. A standard tablet and a modified-release capsule can behave differently even when both contain methylphenidate.

NICE describes other options if methylphenidate is not tolerated or does not help enough after an adequate clinician-led trial. Do not switch medicines, brands or release types using an internet dose-conversion chart.

Treatment includes monitoring and review

ADHD care is not only a prescription. NICE recommends reviewing effectiveness and adverse effects, monitoring pulse and blood pressure, and keeping track of weight; height should also be monitored in children and young people.

Ask the ADHD prescriber what improvement is being measured, when the next review is due, and who to contact if sleep, appetite, mood or physical symptoms change.

Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.

Frequently asked questions

Is methylphenidate first-line for ADHD?

NICE recommends it as a first-line medicine option for children aged 5 and over and young people. For adults, methylphenidate or lisdexamfetamine are first-line options, depending on the clinical assessment.

Can a GP start methylphenidate for suspected ADHD?

NICE recommends specialist assessment and treatment by professionals with relevant ADHD expertise. The route for ongoing prescribing can depend on local shared-care arrangements.

Does methylphenidate cure ADHD?

It can help manage symptoms for some people but is not described as a cure. A clinician should review benefits, adverse effects and ongoing need.

Sources and further reading

This page is based on the following UK sources. Check the leaflet supplied with your own product, as advice can differ between formulations.

Editorial status: Editorial draft — clinical review required before publication. Sources checked on 2 October 2026.

Related information

Read the Methylphenidate overview or continue to another topic: